Late Toxicity and Survival Outcomes Following Intensity-Modulated Radiation Therapy for Recurrent or Second Primary Squamous Cell Carcinomas of the Head and Neck
Vikram Chinnaiyan(University of South Florida), J.J. Caudell(Moffitt Cancer Center), Michelle Echevarria(Moffitt Cancer Center), L. Zhang(University of South Florida), N. Razavian(Moffitt Cancer Center), G.Q. Yang(Moffitt Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 1, 2025
Cited by 0
Related Papers
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline
|Journal of Clinical Oncology|2020|229
Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma
|JAMA Otolaryngology–Head & Neck Surgery|2019|20
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
|International Journal of Radiation Oncology*Biology*Physics|2023|18
Prognostic Factors in Limited-Stage Small Cell Lung Cancer
|JAMA Network Open|2024|11